US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 107.240
  • +0.780+0.73%
Close Apr 29 16:00 ET
  • 107.240
  • 0.0000.00%
Post 20:01 ET
10.61BMarket Cap32.60P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
204.07%130.3M
14.88%389.9M
-13.64%123.5M
114.57%212M
30.05%179.6M
-209.14%-125.2M
Net income from continuing operations
36.68%341.3M
-30.20%103.1M
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
Depreciation and amortization
27.23%27.1M
24.56%7.1M
18.18%6.5M
43.14%7.3M
24.00%6.2M
36.54%21.3M
29.55%5.7M
37.50%5.5M
30.77%5.1M
51.52%5M
Deferred tax
-117.11%-123.1M
-251.94%-31.3M
-730.95%-34.9M
0.48%-41.3M
50.63%-15.6M
-396.86%-56.7M
52.59%20.6M
-146.67%-4.2M
-1,238.71%-41.5M
-10,433.33%-31.6M
Other non cash items
81,550.00%162.9M
232.26%41.2M
-65.04%-20.3M
25,050.00%49.9M
92,200.00%92.1M
-100.28%-200K
-81.66%12.4M
-1,466.67%-12.3M
-110.53%-200K
-108.33%-100K
Change In working capital
-168.09%-19.2M
275.61%94.3M
-90.43%4.4M
-192.40%-86.3M
45.04%-31.6M
141.84%28.2M
-3,480.00%-53.7M
394.87%46M
267.72%93.4M
24.04%-57.5M
-Change in receivables
55.43%-39.8M
109.35%2M
57.57%-12.9M
-519.05%-17.6M
72.90%-11.3M
44.94%-89.3M
53.98%-21.4M
-36.94%-30.4M
127.10%4.2M
46.54%-41.7M
-Change in inventory
-453.70%-19.1M
-1,188.89%-11.6M
-213.79%-3.3M
-431.25%-5.3M
-38.89%1.1M
307.69%5.4M
-123.08%-900K
137.66%2.9M
633.33%1.6M
20.00%1.8M
-Change in payables and accrued expense
-54.90%29M
181.57%67.7M
-68.33%39.4M
-467.28%-59.5M
-377.61%-18.6M
-43.89%64.3M
-320.74%-83M
279.27%124.4M
-50.46%16.2M
-41.74%6.7M
-Change in other working capital
-77.62%10.7M
-29.84%36.2M
63.06%-18.8M
-105.46%-3.9M
88.48%-2.8M
377.91%47.8M
1,374.29%51.6M
-175.14%-50.9M
740.00%71.4M
-127.10%-24.3M
Cash from discontinued investing activities
Operating cash flow
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
204.07%130.3M
14.88%389.9M
-13.64%123.5M
114.57%212M
30.05%179.6M
-209.14%-125.2M
Investing cash flow
Cash flow from continuing investing activities
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
-30.64%-55M
-163.75%-467.1M
-74.57%-201.8M
-58.73%-97.3M
-500.96%-125.9M
-33.23%-42.1M
Capital expenditure reported
-34.98%-38.2M
-35.19%-7.3M
-6.58%-8.1M
-70.59%-11.6M
-31.76%-11.2M
-71.52%-28.3M
-200.00%-5.4M
-547.06%-7.6M
22.73%-6.8M
-11.84%-8.5M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
79.81%-88.6M
68.94%-61M
136.57%32.8M
86.06%-16.6M
-30.36%-43.8M
-272.18%-438.8M
-176.23%-196.4M
-42.38%-89.7M
-396.27%-119.1M
-40.00%-33.6M
Cash from discontinued investing activities
Investing cash flow
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
-30.64%-55M
-163.75%-467.1M
-74.57%-201.8M
-58.73%-97.3M
-500.96%-125.9M
-33.23%-42.1M
Financing cash flow
Cash flow from continuing financing activities
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
127.87%65.3M
43.90%35.4M
64.91%18.8M
101.05%2.9M
34.43%8.2M
Net issuance payments of debt
---308.8M
--0
--0
----
----
--0
--0
--0
----
----
Net common stock issuance
---300M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
86.98%122.1M
-71.75%10M
40.43%26.4M
444.83%15.8M
752.44%69.9M
46.09%65.3M
43.90%35.4M
64.91%18.8M
11.54%2.9M
34.43%8.2M
Cash from discontinued financing activities
Financing cash flow
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
752.44%69.9M
127.87%65.3M
43.90%35.4M
64.91%18.8M
101.05%2.9M
34.43%8.2M
Net cash flow
Beginning cash position
-4.29%259.1M
18.36%357.1M
-12.19%147.7M
262.28%404.3M
-4.29%259.1M
-21.31%270.7M
37.14%301.7M
-1.69%168.2M
-59.86%111.6M
-21.31%270.7M
Current changes in cash
-52.10%-18.1M
-169.93%-115.8M
56.63%209.1M
-553.36%-256.6M
191.26%145.2M
83.47%-11.9M
-182.50%-42.9M
173.01%133.5M
152.95%56.6M
-141.06%-159.1M
Effect of exchange rate changes
--0
-200.00%-300K
----
----
----
123.08%300K
--300K
----
----
----
End cash Position
-6.99%241M
-6.99%241M
18.36%357.1M
-12.19%147.7M
262.28%404.3M
-4.29%259.1M
-4.29%259.1M
37.14%301.7M
-1.69%168.2M
-59.86%111.6M
Free cash flow
54.09%557.2M
99.15%235.2M
-26.66%149.9M
-69.33%53M
189.08%119.1M
11.99%361.6M
-16.36%118.1M
103.38%204.4M
33.64%172.8M
-177.96%-133.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M204.07%130.3M14.88%389.9M-13.64%123.5M114.57%212M30.05%179.6M-209.14%-125.2M
Net income from continuing operations 36.68%341.3M-30.20%103.1M56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M
Depreciation and amortization 27.23%27.1M24.56%7.1M18.18%6.5M43.14%7.3M24.00%6.2M36.54%21.3M29.55%5.7M37.50%5.5M30.77%5.1M51.52%5M
Deferred tax -117.11%-123.1M-251.94%-31.3M-730.95%-34.9M0.48%-41.3M50.63%-15.6M-396.86%-56.7M52.59%20.6M-146.67%-4.2M-1,238.71%-41.5M-10,433.33%-31.6M
Other non cash items 81,550.00%162.9M232.26%41.2M-65.04%-20.3M25,050.00%49.9M92,200.00%92.1M-100.28%-200K-81.66%12.4M-1,466.67%-12.3M-110.53%-200K-108.33%-100K
Change In working capital -168.09%-19.2M275.61%94.3M-90.43%4.4M-192.40%-86.3M45.04%-31.6M141.84%28.2M-3,480.00%-53.7M394.87%46M267.72%93.4M24.04%-57.5M
-Change in receivables 55.43%-39.8M109.35%2M57.57%-12.9M-519.05%-17.6M72.90%-11.3M44.94%-89.3M53.98%-21.4M-36.94%-30.4M127.10%4.2M46.54%-41.7M
-Change in inventory -453.70%-19.1M-1,188.89%-11.6M-213.79%-3.3M-431.25%-5.3M-38.89%1.1M307.69%5.4M-123.08%-900K137.66%2.9M633.33%1.6M20.00%1.8M
-Change in payables and accrued expense -54.90%29M181.57%67.7M-68.33%39.4M-467.28%-59.5M-377.61%-18.6M-43.89%64.3M-320.74%-83M279.27%124.4M-50.46%16.2M-41.74%6.7M
-Change in other working capital -77.62%10.7M-29.84%36.2M63.06%-18.8M-105.46%-3.9M88.48%-2.8M377.91%47.8M1,374.29%51.6M-175.14%-50.9M740.00%71.4M-127.10%-24.3M
Cash from discontinued investing activities
Operating cash flow 52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M204.07%130.3M14.88%389.9M-13.64%123.5M114.57%212M30.05%179.6M-209.14%-125.2M
Investing cash flow
Cash flow from continuing investing activities 72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M-30.64%-55M-163.75%-467.1M-74.57%-201.8M-58.73%-97.3M-500.96%-125.9M-33.23%-42.1M
Capital expenditure reported -34.98%-38.2M-35.19%-7.3M-6.58%-8.1M-70.59%-11.6M-31.76%-11.2M-71.52%-28.3M-200.00%-5.4M-547.06%-7.6M22.73%-6.8M-11.84%-8.5M
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale 79.81%-88.6M68.94%-61M136.57%32.8M86.06%-16.6M-30.36%-43.8M-272.18%-438.8M-176.23%-196.4M-42.38%-89.7M-396.27%-119.1M-40.00%-33.6M
Cash from discontinued investing activities
Investing cash flow 72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M-30.64%-55M-163.75%-467.1M-74.57%-201.8M-58.73%-97.3M-500.96%-125.9M-33.23%-42.1M
Financing cash flow
Cash flow from continuing financing activities -845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M752.44%69.9M127.87%65.3M43.90%35.4M64.91%18.8M101.05%2.9M34.43%8.2M
Net issuance payments of debt ---308.8M--0--0----------0--0--0--------
Net common stock issuance ---300M------------------0----------------
Proceeds from stock option exercised by employees 86.98%122.1M-71.75%10M40.43%26.4M444.83%15.8M752.44%69.9M46.09%65.3M43.90%35.4M64.91%18.8M11.54%2.9M34.43%8.2M
Cash from discontinued financing activities
Financing cash flow -845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M752.44%69.9M127.87%65.3M43.90%35.4M64.91%18.8M101.05%2.9M34.43%8.2M
Net cash flow
Beginning cash position -4.29%259.1M18.36%357.1M-12.19%147.7M262.28%404.3M-4.29%259.1M-21.31%270.7M37.14%301.7M-1.69%168.2M-59.86%111.6M-21.31%270.7M
Current changes in cash -52.10%-18.1M-169.93%-115.8M56.63%209.1M-553.36%-256.6M191.26%145.2M83.47%-11.9M-182.50%-42.9M173.01%133.5M152.95%56.6M-141.06%-159.1M
Effect of exchange rate changes --0-200.00%-300K------------123.08%300K--300K------------
End cash Position -6.99%241M-6.99%241M18.36%357.1M-12.19%147.7M262.28%404.3M-4.29%259.1M-4.29%259.1M37.14%301.7M-1.69%168.2M-59.86%111.6M
Free cash flow 54.09%557.2M99.15%235.2M-26.66%149.9M-69.33%53M189.08%119.1M11.99%361.6M-16.36%118.1M103.38%204.4M33.64%172.8M-177.96%-133.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
BEOKA
870199
+29.96%
CG MED EQUIP.
838810
+24.39%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.